These peptides have been shown to be efficient in attenuating BBB disruption upon brain injury and subarachnoid hemorrhage, mediating neuroprotection, and reducing BBB permeability, where their effects seem to be linked to the activation of the CypA-NF-κB-MMP-9 pathway [146]. The gene discussed is PPIA; the disease is subarachnoid hemorrhage.